dc.contributor.author | Derbentli, Sengul | |
dc.contributor.author | Aktas, Gülseren | |
dc.date.accessioned | 2021-03-04T08:32:34Z | |
dc.date.available | 2021-03-04T08:32:34Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Aktas G., Derbentli S., "In vitro activity of daptomycin combined with dalbavancin and linezolid, and dalbavancin with linezolid against MRSA strains", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.72, sa.2, ss.441-443, 2017 | |
dc.identifier.issn | 0305-7453 | |
dc.identifier.other | av_63d15539-37a8-41a0-a602-99e1a350bdd5 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/69484 | |
dc.identifier.uri | https://doi.org/10.1093/jac/dkw416 | |
dc.description.abstract | Objectives: Combination therapies have a distinct advantage over monotherapies in terms of their broad spectrum, synergistic effect and prevention of the emergence of drug resistance. In the present study, the in vitro antibacterial activity of daptomycin combinations with linezolid and dalbavancin, and dalbavancin with linezolid were evaluated against 30 clinical MRSA strains. | |
dc.language.iso | eng | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Eczacılık | |
dc.subject | Sağlık Bilimleri | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Mikrobiyoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | İmmünoloji | |
dc.subject | BULAŞICI HASTALIKLAR | |
dc.title | In vitro activity of daptomycin combined with dalbavancin and linezolid, and dalbavancin with linezolid against MRSA strains | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 72 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 441 | |
dc.identifier.endpage | 443 | |
dc.contributor.firstauthorID | 97052 | |